Nykredit A S purchased a new position in Moderna, Inc. (NASDAQ: MRNA) during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 13,042 shares of the company's stock, valued at approximately $913,000. A number of other institutional investors have also recently added
Read on defenseworld.net